胃癌术后早期腹腔内化疗30例临床观察  

Clinical effect of early postoperative intraperitoneal chemotherapy on 30 patients with gastric cancer

作　　者：王兆平 夏建兵 唐雪红 季新忠 

机构地区：[1]上海市奉贤区奉城医院,上海201411

出　　处：《中国现代医学杂志》2007年第5期589-590,594,共3页China Journal of Modern Medicine

摘　　要：目的探讨胃癌术后早期腹腔内化疗(EPIC)与术后并发症以及对预后的影响。方法对30例胃癌患者于根治术后行EPIC后的情况进行总结分析。结果EPIC组术后2年生存率显著高于常规组(P<0.05),EPIC组术后血液学指标与常规组比较差异无显著性;EPIC组术后肛门排气时间稍长于常规组。结论EPIC能提高胃癌患者术后生存率,不增加术后并发症的发生。[Objective] To investigate the relation between early postoperative intraporitoneal chemotherapy （EPIC） and the postoperative complications after curative resection, and its effect on patient＇s prognosis of gastric cancer. [Methods] The prognosis and postoperative complications of 61 cases with gastric cancer undergone curative resection were analyzed, of 61 cases, 30 belonged to EPIC group, the remaining 31 cases routine group. [Resuit] The 2-year survival rate of EPIC group was significantly higher than that of routine group （P 〈0.05）. The parameter of blood system between there two groups had no significant difference. The time of anal discharging gas of EPIC group was longer than that of routine group. [Conclusion] EPIC can improve the prognosis of gastric cancer and does not influence the occurrence of postoperative complications.

关 键 词：胃癌 腹腔内化疗 

分 类 号：R735.2[医药卫生—肿瘤]